A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight

NCT04667377 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

387

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: BI 456906
DRUG: Placebo

Sponsor

Boehringer Ingelheim